OSTX
OS Therapies Incorporated
0.8722
-0.04 (-4.48%)
52w low 0.5800
2.25 high
17.5% of range
Financial Analysis
| Ratio | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| Return on Equity | -- | -91.8% | -189.1% | 220.8% | 96.1% | 72.5% | |
| Return on Assets | -- | -44.0% | -76.8% | -196.8% | -142.4% | -87.2% | |
| Return on Inv Capital | -- | -72.5% | -149.4% | 174.5% | 86.0% | 57.2% | |
| Liquidity | |||||||
| Current Ratio | -- | 1.03x | 0.56x | 0.03x | 0.05x | 0.18x | |
| Quick Ratio | -- | 1.03x | 0.56x | 0.03x | 0.05x | 0.18x | |
| Cash Ratio | -- | 0.81x | 0.45x | 0.02x | 0.05x | 0.01x | |
| Leverage | |||||||
| Debt / Equity | -- | -- | -- | -- | -0.12x | -- | |
| Net Debt / EBITDA | -- | -- | -- | -- | -0.04x | -- | |
| Interest Coverage | -- | -- | -- | -- | -136.99x | -1545.75x | |
| Equity Multiplier | -- | 2.09x | 2.46x | -1.12x | -0.67x | -0.83x | |
| Efficiency | |||||||
| Asset Turnover | -- | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | |
| Op CF / Net Income | -- | 0.52x | 0.68x | 0.28x | 0.44x | 0.64x | |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--